[1]
2021. COMPARISON OF SARS-COV-2 ANTIBODY PRODUCTION BY 2-DOSE CORONAVAC, 2-DOSE VAXZEVRIA, 2-DOSE CORONAVAC-VAXZEVRIA HETEROLOGOUS VACCINATION AND POST-INFECTION. The Southeast Asian Journal of Tropical Medicine and Public Health. 52, 5 (Oct. 2021), 689–695.